placeholder newsslider

News

ARVO 2021 going fully virtual

The Association for Research in Vision and Ophthalmology announced the switch to a virtual format this week for its annual meeting, originally scheduled for May 2-6 in San Francisco.

Heidelberg imaging platforms poised for future of ophthalmology

Ram Liebenthal, U.S. general manager for Heidelberg Engineering, discusses how the company continues to invest in the Spectralis platform in terms of hardware and software improvements.

AAO Appoints Emily Chew, MD, as Editor-in-Chief of Ophthalmology Science

The American Academy of Ophthalmology today announced the appointment of Emily Chew, MD, as editor in chief of Ophthalmology Science, the fourth and newest addition to the Academy’s Ophthalmology® family of journals. Dr. Chew is a highly respected medical retina specialist and editor, with extensive experience in the design and implementation of clinical trials.

American Academy of Ophthalmology Leads Global Initiative to Address Worldwide Myopia Epidemic

The number of Americans who are nearsighted has nearly doubled over the last 50 years to about 41.6 percent. This upward trend is evident in nearly every corner of the world, but nowhere near as dramatic as in East and Southeast Asia, where 80 to 90 percent of children and young adults are myopic.

Alcon showcases advanced IOL technology for presbyopia

Kristen Brotherson, vice president, US surgical marketing for Alcon, discusses some of the recent advances in cataract surgery-related technologies, including a new advanced lens for patients with presbyopia (AcrySof IQ Vivity IOL).

Major European research scheme gets €4-billion boost

Last-minute budget increase still leaves the upcoming Horizon Europe programme billions short of campaigners’ hopes.

US president-elect Joe Biden must quickly restore science to government

The election of Biden and Kamala Harris is a win for facts, research and empathy. Each of these must be deployed to fight the pandemic, combat misinformation, mitigate climate change and rebuild the United States’ global relationships.

Genentech provides update on presentations, product portfolio

Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.

Scientists relieved as Joe Biden wins tight US presidential election

The new president has the opportunity to reverse four years of anti-science policies — but he has a hard road ahead as he inherits a nation divided.

Blindness and sight loss to double by 2050

Blindness and severe vision impairment is predicted to affect almost 900 million people worldwide by 2050—up from around 338 million today, according to a new pre-print study accepted by The Lancet and highlighted on World Sight Day.

Commitment to ensure ‘systematic and structural cooperation’ between the EIC and the EIT

The Letter of Intent sets about common principles, including commitment to the innovators, agility, reactivity, speed and streamlining of innovation policy, resources and efforts, enhancing synergies and efficiencies across the two programmes.

How we formed a ‘journal club’ for equity in science

You can start and maintain your own group to help scientists of all backgrounds thrive.

Australian research gets billion-dollar boost in sweeping stimulus budget

First budget since pandemic began offers much-needed funds to universities and national science agency.

Leuven is European Capital of Innovation 2020

Leuven is a mission-driven city that excels in innovative governance models. It offers its people an opportunity to get involved in critical decision-making processes. But it’s an honour to recognise the initiatives of all six winners. Their vibrant innovation ecosystems are an inspiration to all European cities.

Do eyeglasses help keep coronavirus out? Johns Hopkins expert says more evidence needed

During the current pandemic, we've all been advised to protect ourselves from infection by the SARS-CoV-2 virus that causes COVID-19 by masking, physical distancing and frequent hand-washing. In the Sept. 17 issue of JAMA Ophthalmology, a research team in China suggests that a fourth defensive measure also might be helpful: eye protection.